Investor Taunts Omega Protein, Suggests Ripe Conditions For Sale
This article was originally published in The Tan Sheet
Wynnefield Capital, in an SEC filing, includes a letter it sent to Omega Protein noting M&A activity in the fish product market creates promising conditions for the firm’s sale. The group also makes candid observations about its lack of faith in Omega Protein’s management.
You may also be interested in...
Ramirez appointed FTC chair; budget sequester slows FDA travel, training; ChromaDex divests BluScience brand; Omega Protein buys whey firm; Vitamin Shoppe absorbs integration costs; Vitacost trims net loss in Q4; chemical regulation champion Lautenberg to retire; USANA expands in China.
Omega Protein acquired Cyvex Nutrition and InCon Processing in the past 15 months to enter the dietary supplement market and vertically integrate its omega-3 fish oil supply chain. The firm gained from a one-time settlement payment in 2011, but saw underlying earnings fall.
Senate votes down Illinois Democrat’s proposal to amend stopgap appropriations bill with language calling for establishing mandatory products listing program in FDA. But proposal to give FDA MPL authority likely will return in Congress, says Natural Products Association.